This DOES NOT give us a time frame for commercialization. Not even a rough road map, which would do, but they're not even doing that. Also late last year they told us that they had sent a "new and improved" (my words) Biochip to a Luxumberg fabricator when at the time they said would be returned about mid year 2024. But they're not saying anything about that any more. What happened to it? Was it a successful fabrication run or NOT. Ive written to them about it but no response.
I think we shareholders have been very patient and loyal watching this gradually lose 90% of its value in the last 2.5 years or so. Being silent and compliant and not asking for updates on our investment has not worked very well for us and 6 weeks ago we all got a kick in the guts when we were told that the CEO, "whose baby" (my words) this thing was supposed to be decides he's leaving. Its time we shareholders were a bit more proactive about this investment IMO.
AXE Price at posting:
24.5¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)